The Use of Peptides in the Treatment of Fragile X Syndrome: Challenges and Opportunities
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Use of Peptides in the Treatment of Fragile X Syndrome: Challenges and Opportunities
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-11-04
DOI
10.3389/fpsyt.2021.754485
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders
- (2021) Sébastien Delhaye et al. MOLECULAR PSYCHIATRY
- Trends in peptide drug discovery
- (2021) Markus Muttenthaler et al. NATURE REVIEWS DRUG DISCOVERY
- The molecular biology of FMRP: new insights into fragile X syndrome
- (2021) Joel D. Richter et al. NATURE REVIEWS NEUROSCIENCE
- Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial
- (2021) Elizabeth M. Berry-Kravis et al. NATURE MEDICINE
- The safety and efficacy of metformin in fragile X syndrome: An open-label study
- (2021) Mélodie Proteau-Lemieux et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Fragile X syndrome and associated disorders: Clinical aspects and pathology
- (2020) Maria Jimena Salcedo-Arellano et al. NEUROBIOLOGY OF DISEASE
- Reactivation of FMR1 gene expression is a promising strategy for fragile X syndrome therapy
- (2020) Ekaterina M. Shitik et al. GENE THERAPY
- Peptide Therapeutics 2.0
- (2020) Beatriz G. de la Torre et al. MOLECULES
- Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides
- (2020) Ines Greco et al. Scientific Reports
- Bioinformatics and Biosimulations as Toolbox for Peptides and Peptidomimetics Design: Where Are We?
- (2020) Ilda D’Annessa et al. Frontiers in Molecular Biosciences
- Inhibition of PDE2 and PDE4 synergistically improves memory consolidation processes
- (2020) Dean Paes et al. NEUROPHARMACOLOGY
- Peptidomimetics: A Synthetic Tool for Inhibiting Protein–Protein Interactions in Cancer
- (2019) Lloyd Mabonga et al. International Journal of Peptide Research and Therapeutics
- A Comprehensive Review on Current Advances in Peptide Drug Development and Design
- (2019) Andy Chi-Lung Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders
- (2019) Mark E. Gurney et al. JOURNAL OF MEDICINAL CHEMISTRY
- Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features
- (2019) Emma K. Baker et al. Molecular Autism
- Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin‐two cases
- (2019) Dragana Protic et al. Molecular Genetics & Genomic Medicine
- A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome
- (2019) Helen Heussler et al. Journal of Neurodevelopmental Disorders
- Metformin treatment in young children with fragile X syndrome
- (2019) Hazel Maridith B. Biag et al. Molecular Genetics & Genomic Medicine
- The loss of β adrenergic receptor mediated release potentiation in a mouse model of fragile X syndrome
- (2019) Nuria García-Font et al. NEUROBIOLOGY OF DISEASE
- Deciphering the mechanistic effects of eIF4E phosphorylation on mRNA‐cap recognition
- (2019) Dilraj Lama et al. PROTEIN SCIENCE
- Peptides, Peptidomimetics, and Carbohydrate–Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer’s Disease
- (2018) Philip Ryan et al. ACS Chemical Neuroscience
- Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases
- (2018) Mohammad Hassan Baig et al. BIOMEDICINE & PHARMACOTHERAPY
- OUP accepted manuscript
- (2018) CEREBRAL CORTEX
- Structural motifs in eIF4G and 4E-BPs modulate their binding to eIF4E to regulate translation initiation in yeast
- (2018) Stefan Grüner et al. NUCLEIC ACIDS RESEARCH
- HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein
- (2018) Thomas Maurin et al. NUCLEIC ACIDS RESEARCH
- Handling FMRP and its molecular partners: Structural insights into Fragile X Syndrome
- (2018) Ilda D'Annessa et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Protein Synthesis Initiation in Eukaryotic Cells
- (2018) William C. Merrick et al. Cold Spring Harbor Perspectives in Biology
- Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours
- (2018) Bumwhee Lee et al. Nature Biomedical Engineering
- Stress Odorant Sensory Response Dysfunction in Drosophila Fragile X Syndrome Mutants
- (2018) Alaura Androschuk et al. Frontiers in Molecular Neuroscience
- Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders
- (2018) Ilse Gantois et al. Annual Review of Medicine
- MiR-219 represses expression of dFMR1 in Drosophila melanogaster
- (2018) Chao Wang et al. LIFE SCIENCES
- Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome
- (2017) Angélique Quartier et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment
- (2017) Aleksandra Ellert-Miklaszewska et al. Future Medicinal Chemistry
- Metformin ameliorates core deficits in a mouse model of fragile X syndrome
- (2017) Ilse Gantois et al. NATURE MEDICINE
- Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
- (2017) Elizabeth M. Berry-Kravis et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results
- (2017) Eriene A Youssef et al. NEUROPSYCHOPHARMACOLOGY
- Reducing eIF4E-eIF4G interactions restores the balance between protein synthesis and actin dynamics in fragile X syndrome model mice
- (2017) Emanuela Santini et al. Science Signaling
- Rac1 GTPase activates the WAVE regulatory complex through two distinct binding sites
- (2017) Baoyu Chen et al. eLife
- Reducing eIF4E-eIF4G interactions restores the balance between protein synthesis and actin dynamics in fragile X syndrome model mice
- (2017) Emanuela Santini et al. Science Signaling
- Fragile X syndrome
- (2017) Randi J. Hagerman et al. Nature Reviews Disease Primers
- Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D)
- (2017) Mark E. Gurney et al. Scientific Reports
- Anti-Cancer Effect of Cap-Translation Inhibitor 4EGI-1 in Human Glioma U87 Cells: Involvement of Mitochondrial Dysfunction and ER Stress
- (2016) Ming Wu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Stapled peptide design: principles and roles of computation
- (2016) Yaw Sing Tan et al. DRUG DISCOVERY TODAY
- Pharmacotherapy for Fragile X Syndrome: Progress to Date
- (2016) Matthew H. Davenport et al. DRUGS
- A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome
- (2016) Laura Greiss Hess et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- The Structures of eIF4E-eIF4G Complexes Reveal an Extended Interface to Regulate Translation Initiation
- (2016) Stefan Grüner et al. MOLECULAR CELL
- Insulin signaling misregulation underlies circadian and cognitive deficits in a Drosophila fragile X model
- (2016) R E Monyak et al. MOLECULAR PSYCHIATRY
- Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials
- (2016) Elizabeth Berry-Kravis et al. Science Translational Medicine
- Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X Syndrome
- (2016) Elisabetta Tabolacci et al. Genes
- Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome
- (2016) Nina Xie et al. PLoS One
- Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases
- (2015) M. Elizabeth Meredith et al. AAPS Journal
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- Mextli proteins use both canonical bipartite and novel tripartite binding modes to form eIF4E complexes that display differential sensitivity to 4E-BP regulation
- (2015) Daniel Peter et al. GENES & DEVELOPMENT
- MD and Docking Studies Reveal That the Functional Switch of CYFIP1 is Mediated by a Butterfly-like Motion
- (2015) Daniele Di Marino et al. Journal of Chemical Theory and Computation
- PDE-4 Inhibition Rescues Aberrant Synaptic Plasticity in Drosophila and Mouse Models of Fragile X Syndrome
- (2015) C. H. Choi et al. JOURNAL OF NEUROSCIENCE
- Targeting the translation machinery in cancer
- (2015) Mamatha Bhat et al. NATURE REVIEWS DRUG DISCOVERY
- RNA-mediated epigenetic regulation of gene expression
- (2015) Daniel Holoch et al. NATURE REVIEWS GENETICS
- Dysregulation and restoration of translational homeostasis in fragile X syndrome
- (2015) Joel D. Richter et al. NATURE REVIEWS NEUROSCIENCE
- A 3′ untranslated region variant inFMR1eliminates neuronal activity-dependent translation of FMRP by disrupting binding of the RNA-binding protein HuR
- (2015) Joshua A. Suhl et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A unique binding mode of the eukaryotic translation initiation factor 4E for guiding the design of novel peptide inhibitors
- (2015) Daniele Di Marino et al. PROTEIN SCIENCE
- Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury
- (2015) A Vercelli et al. Cell Death & Disease
- Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons
- (2015) Chul-Yong Park et al. Cell Reports
- Effect of lovastatin on behavior in children and adults with fragile X syndrome: An open-label study
- (2014) Artuela Çaku et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Fragile X syndrome due to a missense mutation
- (2014) Leila K Myrick et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Pharmacological rescue of Ras signaling, GluA1-dependent synaptic plasticity, and learning deficits in a fragile X model
- (2014) C.-S. Lim et al. GENES & DEVELOPMENT
- Quantitative Phosphoproteomics of Murine Fmr1-KO Cell Lines Provides New Insights into FMRP-Dependent Signal Transduction Mechanisms
- (2014) Katarina Matic et al. JOURNAL OF PROTEOME RESEARCH
- Activity-dependent alterations in the sensitivity to BDNF-TrkB signaling may promote excessive dendritic arborization and spinogenesis in fragile X syndrome in order to compensate for compromised postsynaptic activity
- (2014) Sang Woo Kim et al. MEDICAL HYPOTHESES
- Reduced Phenotypic Severity Following Adeno-Associated Virus-Mediated Fmr1 Gene Delivery in Fragile X Mice
- (2014) Shervin Gholizadeh et al. NEUROPSYCHOPHARMACOLOGY
- An eIF4E-interacting peptide induces cell death in cancer cell lines
- (2014) M Masse et al. Cell Death & Disease
- 4E-BPs require non-canonical 4E-binding motifs and a lateral surface of eIF4E to repress translation
- (2014) Cátia Igreja et al. Nature Communications
- Pharmacogenetic Inhibition of eIF4E-Dependent Mmp9 mRNA Translation Reverses Fragile X Syndrome-like Phenotypes
- (2014) Christos G. Gkogkas et al. Cell Reports
- Future directions for peptide therapeutics development
- (2013) Allan A. Kaspar et al. DRUG DISCOVERY TODAY
- Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome
- (2013) Chiara Pastori et al. HUMAN GENETICS
- Molecular dynamics simulations show how the FMRP Ile304Asn mutation destabilizes the KH2 domain structure and affects its function
- (2013) Daniele Di Marino et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- A Randomized Double-Blind, Placebo-Controlled Trial of Minocycline in Children and Adolescents with Fragile X Syndrome
- (2013) Mary Jacena S. Leigh et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- Targeting the endocannabinoid system in the treatment of fragile X syndrome
- (2013) Arnau Busquets-Garcia et al. NATURE MEDICINE
- Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome
- (2013) Emily K. Osterweil et al. NEURON
- Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice
- (2013) L.E. Dansie et al. NEUROSCIENCE
- Resilience to audiogenic seizures is associated with p-ERK1/2 dephosphorylation in the subiculum of Fmr1 knockout mice
- (2013) Giulia Curia et al. Frontiers in Cellular Neuroscience
- Rational Optimization of Conformational Effects Induced By Hydrocarbon Staples in Peptides and their Binding Interfaces
- (2013) Dilraj Lama et al. Scientific Reports
- The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction
- (2012) G Descamps et al. BRITISH JOURNAL OF CANCER
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics
- (2012) Claudia Bagni et al. JOURNAL OF CLINICAL INVESTIGATION
- Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome
- (2012) Kwang-Mook Jung et al. Nature Communications
- Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase
- (2011) S. S. Siller et al. Disease Models & Mechanisms
- Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology
- (2011) P. Michaluk et al. JOURNAL OF CELL SCIENCE
- Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond
- (2011) Christina Gross et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization
- (2010) Luca Gentilucci et al. CURRENT PHARMACEUTICAL DESIGN
- Dysregulation of mTOR Signaling in Fragile X Syndrome
- (2010) A. Sharma et al. JOURNAL OF NEUROSCIENCE
- Physiological Activation of Synaptic Rac>PAK (p-21 Activated Kinase) Signaling Is Defective in a Mouse Model of Fragile X Syndrome
- (2010) L. Y. Chen et al. JOURNAL OF NEUROSCIENCE
- Structure and control of the actin regulatory WAVE complex
- (2010) Zhucheng Chen et al. NATURE
- Abnormal mGlu 5 Receptor/Endocannabinoid Coupling in Mice Lacking FMRP and BC1 RNA
- (2010) Mauro Maccarrone et al. NEUROPSYCHOPHARMACOLOGY
- Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome
- (2010) Feng Pan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
- (2009) Nahum Sonenberg et al. CELL
- Inhibition of Ovarian Cancer Growth by a Tumor-Targeting Peptide That Binds Eukaryotic Translation Initiation Factor 4E
- (2009) S. Y. Ko et al. CLINICAL CANCER RESEARCH
- Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome
- (2009) Z Zeier et al. GENE THERAPY
- Fragile X mental retardation protein control of neuronal mRNA metabolism: Insights into mRNA stability
- (2009) Silvia De Rubeis et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- The Fragile X Syndrome Protein Represses Activity-Dependent Translation through CYFIP1, a New 4E-BP
- (2008) Ilaria Napoli et al. CELL
- Downregulation of Tonic GABAergic Inhibition in a Mouse Model of Fragile X Syndrome
- (2008) Giulia Curia et al. CEREBRAL CORTEX
- Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy
- (2008) Lorenzo A. Cingolani et al. NATURE REVIEWS NEUROSCIENCE
- Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome
- (2008) S. H. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Abnormal Striatal GABA Transmission in the Mouse Model for the Fragile X Syndrome
- (2007) Diego Centonze et al. BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now